A detailed history of N Verses Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 400 shares of MRK stock, worth $39,880. This represents 0.02% of its overall portfolio holdings.

Number of Shares
400
Previous 2,600 84.62%
Holding current value
$39,880
Previous $322 Million 85.89%
% of portfolio
0.02%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$111.15 - $128.97 $244,530 - $283,734
-2,200 Reduced 84.62%
400 $45.4 Million
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $259,980 - $279,216
2,100 Added 420.0%
2,600 $322 Million
Q1 2024

Apr 25, 2024

BUY
$113.24 - $131.95 $56,620 - $65,975
500 New
500 $66 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.